Eyenovia, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
EYEN Nasdaq 2834 www.eyenovia.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Eyenovia, Inc.

Eyenovia Announces Leading Proxy Advisory Firms, ISS and Glass Lewis, Recommend Eyenovia Stockholders Vote “FOR” Proposed Reverse Stock Split at Upcoming Special Meeting of Stockholders - Jan 15th, 2025 12:00 pm
Eyenovia Engages Chardan as Advisor for Review of Strategic Alternatives - Jan 6th, 2025 12:00 pm
Eyenovia, Inc. Announces Pricing of $1.9 Million Registered Direct Offering - Dec 6th, 2024 1:00 pm
Eyenovia, Inc. Announces Pricing of $1.3 Million Registered Direct Offering - Nov 25th, 2024 1:00 pm
Eyenovia taking additional actions to reduce personnel-related costs by over 70% - Nov 23rd, 2024 12:05 pm
Eyenovia Provides Update on Restructuring Efforts - Nov 22nd, 2024 12:00 pm
Eyenovia downgraded to Neutral from Buy at H.C. Wainwright - Nov 19th, 2024 11:15 am
Eyenovia Stock Tumbles on Termination of Phase III Myopia Study - Nov 18th, 2024 2:49 pm
Eyenovia stock plummets following Phase III myopia trial failure - Nov 18th, 2024 12:38 pm
Sector Update: Health Care Stocks Slide Late Afternoon - Nov 15th, 2024 9:01 pm
Eyenovia Stock Sinks As Pivotal Trial Fails To Hit Primary Efficacy Goal, Analyst Downgrades Due To Limited Capital And Near Term Upside From Pipeline - Nov 15th, 2024 6:15 pm
Eyenovia Third Quarter 2024 Earnings: Misses Expectations - Nov 15th, 2024 12:14 pm
Eyenovia Provides Update on Phase 3 CHAPERONE Study - Nov 15th, 2024 12:00 pm
Eyenovia Inc (EYEN) Q3 2024 Earnings Call Highlights: Strategic Advances Amid Financial Challenges - Nov 13th, 2024 7:17 am
Eyenovia, Inc. (EYEN) Reports Q3 Loss, Misses Revenue Estimates - Nov 12th, 2024 10:45 pm
Eyenovia Reports Third Quarter 2024 Financial Results and Provides Corporate Update - Nov 12th, 2024 9:05 pm
Eyenovia to Report Third Quarter 2024 Results on Tuesday, November 12th - Nov 7th, 2024 12:00 pm
Eyenovia Announces Publication of Study Demonstrating Favorable Impact on the Ocular Surface of Medication Delivered with the Optejet® - Oct 23rd, 2024 11:00 am
Eyenovia Announces Presentation of Phase 3 Clobetasol Study Results at the American Academy of Ophthalmology (AAO) 2024 Expo - Oct 16th, 2024 11:00 am
Here's Why Eyenovia (EYEN) Is a Great 'Buy the Bottom' Stock Now - Oct 14th, 2024 1:55 pm